Work

A randomized, placebo-controlled, double-blinded, crossover trial of pioglitazone for severe asthma

Year: 2017

Type: article

Study design: Clinical Trial

Source: Journal of Allergy and Clinical Immunology

DOI: 10.1016/j.jaci.2017.05.033

Authors: Maryann Kaler, Amisha V. Barochia, Nargues A. Weir, Rosemarie A. Cuento, Mario Stylianou, Mark J. Roth, Armando C. Filie, Ellen C. Vaughey, Steven D. Nathan, Stewart J. Levine

Institutions: National Institutes of Health, National Heart, Lung, and Blood Institute, Inova Fairfax Hospital, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute

Award: Study of Pioglitazone Hydrochloride in Severe, Refractory Asthma

OpenAlex ID: W2626083612

FWCI: 1.819

Cites: 9

Cited by: 30

Related to: 10